ULK1 and Alzheimer disease: Inhibit NACHT, LRR, and NLRP3 inflammasomes to reduce neuroinflammation and activate AMPK/ULK1 pathway to induce autophagy, thereby restore BBB function and reducing AD related pathological damage.